Nicotinamide ( DrugBank: Nicotinamide )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	4
49	全身性エリテマトーデス	1

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05589766 (ClinicalTrials.gov)	November 28, 2022	13/10/2022	N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease	N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease	Parkinson Disease	Dietary Supplement: Nicotinamide Riboside;Other: Placebo	Haukeland University Hospital	NULL	Recruiting	40 Months	100 Years	All	80	N/A	Norway
2	NCT03568968 (ClinicalTrials.gov)	May 15, 2020	14/6/2018	A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease	A Randomized Controlled Trial of NicotinamideSupplementation in Early Parkinson's Disease: the NOPAR ...	Parkinson Disease	Dietary Supplement: Nicotinamide Riboside;Drug: Placebo	Haukeland University Hospital	NULL	Recruiting	18 Years	N/A	All	400	N/A	Norway
3	NCT03816020 (ClinicalTrials.gov)	March 9, 2019	7/12/2018	NAD-supplementation in Drug naïve Parkinson's Disease	NAD-PARK: A Double-blinded Randomized Pilot Trial of NAD-supplementation in Drug naïve Parkinson's D ...	Parkinson Disease;Neurodegenerative Diseases	Dietary Supplement: Nicotinamide Riboside;Other: Placebo	Haukeland University Hospital	NULL	Completed	18 Years	N/A	All	30	N/A	Norway
4	EUCTR2004-005034-39-GB (EUCTR)	17/05/2005	20/04/2005	Nicotinamide,vitamin B3, metabolic pathways in patients with early idiopathic parkinson's disease	Nicotinamide,vitamin B3, metabolic pathways in patients with early idiopathic parkinson's disease	Idiopathic Parkinson's disease	Trade Name: Nicotinamide Product Name: NICOTINAMIDE INN or Proposed INN: Nicotinamide	Queen Elizabeth Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			United Kingdom

First Previous1Next Last

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03260166 (ClinicalTrials.gov)	August 31, 2017	10/8/2017	Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus	An Open-label Study for Assessing the Efficacy and Safety of NicotinamideTreatment for Lupus-associa ...	Cutaneous Lupus Erythematosus;Systemic Lupus Erythematosus Rash	Drug: nicotinamide	Second Xiangya Hospital of Central South University	National Natural Science Foundation of China;Hunan Provincial Natural Science Foundation of China;Na ...	Active, not recruiting	18 Years	65 Years	All	40	Phase 2	China

First Previous1Next Last

先頭へ